NCT07063628Completed
Triglyceride-Glucose Indices and Left Ventricular Speckle Tracking in Predicting Coronary Artery Disease Severity
Comparative Assessment of Triglyceride-Glucose Indices and Left Ventricular Speckle Tracking in Predicting Coronary Artery Disease Severity: Insights From Gensini Scoring
Source: ClinicalTrials.gov · Last updated 16 Jul 2025
Brief summary (registry, in English)
Our study specifically will address the value of modified triglyceride glucose indices versus left ventricular speckle tracking in prediction of severity of coronary artery disease assessed by Gensini score.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 508 (actual)
- First submitted
- 3 Jul 2025
- Start date
- 30 Apr 2025
- Primary completion date
- 1 Jul 2025
- Lead sponsor
- Damanhour University
- Diseases
- Coronary artery disease
- NCT number
- NCT07063628
What you commit to
- Study type: Observational
- Participants enrolled: 508
- From 30 Apr 2025 to the primary completion date, 1 Jul 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients with acute coronary syndrome, arrhythmias, previous coronary interventions (PCI or CABG), or inability to undergo echocardiographic assessment.
Who the study is looking for
- diagnosis of CAD with ≥50% stenosis in at least one major coronary artery.
Age in the registry: 38 years to 80 years · Sex: All
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Rehab Hussein Werida Coordinator of this site? Confirm its status | Damanhūr | Egypt | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.